These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11761630)

  • 21. Sex and informant effects on diagnostic comorbidity in an adolescent community sample.
    Romano E; Tremblay RE; Vitaro F; Zoccolillo M; Pagani L
    Can J Psychiatry; 2005 Jul; 50(8):479-89. PubMed ID: 16127966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is bipolar disorder specifically associated with panic disorder in youths?
    Birmaher B; Kennah A; Brent D; Ehmann M; Bridge J; Axelson D
    J Clin Psychiatry; 2002 May; 63(5):414-9. PubMed ID: 12019666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
    McElroy SL; Altshuler LL; Suppes T; Keck PE; Frye MA; Denicoff KD; Nolen WA; Kupka RW; Leverich GS; Rochussen JR; Rush AJ; Post RM
    Am J Psychiatry; 2001 Mar; 158(3):420-6. PubMed ID: 11229983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder.
    Sachs GS; Baldassano CF; Truman CJ; Guille C
    Am J Psychiatry; 2000 Mar; 157(3):466-8. PubMed ID: 10698829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comorbidity of attention deficit hyperactivity disorder in juvenile bipolar disorder.
    Jaideep T; Reddy YC; Srinath S
    Bipolar Disord; 2006 Apr; 8(2):182-7. PubMed ID: 16542189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
    Henry C; Van den Bulke D; Bellivier F; Etain B; Rouillon F; Leboyer M
    J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.
    Singh JB; Zarate CA
    Bipolar Disord; 2006 Dec; 8(6):696-709. PubMed ID: 17156156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.
    Biederman J; Faraone S; Milberger S; Guite J; Mick E; Chen L; Mennin D; Marrs A; Ouellette C; Moore P; Spencer T; Norman D; Wilens T; Kraus I; Perrin J
    Arch Gen Psychiatry; 1996 May; 53(5):437-46. PubMed ID: 8624187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bipolar disorder and comorbid anxiety disorders in children and adolescents.
    Dineen Wagner K
    J Clin Psychiatry; 2006; 67 Suppl 1():16-20. PubMed ID: 16426112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbidity of Attention Deficit Hyperactivity Disorder and Generalized Anxiety Disorder in children and adolescents.
    Melegari MG; Bruni O; Sacco R; Barni D; Sette S; Donfrancesco R
    Psychiatry Res; 2018 Dec; 270():780-785. PubMed ID: 30551325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic treatment of pediatric bipolar disorder.
    Nandagopal JJ; DelBello MP; Kowatch R
    Child Adolesc Psychiatr Clin N Am; 2009 Apr; 18(2):455-69, x. PubMed ID: 19264273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiating bipolar disorder in Turkish prepubertal children with attention-deficit hyperactivity disorder.
    Diler RS; Uguz S; Seydaoglu G; Erol N; Avci A
    Bipolar Disord; 2007 May; 9(3):243-51. PubMed ID: 17430299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.
    Wilens TE; Biederman J; Mick E; Faraone SV; Spencer T
    J Nerv Ment Dis; 1997 Aug; 185(8):475-82. PubMed ID: 9284860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity in pediatric bipolar disorder: prevalence, clinical impact, etiology and treatment.
    Frías Á; Palma C; Farriols N
    J Affect Disord; 2015 Mar; 174():378-89. PubMed ID: 25545605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiety symptoms and syndromes in bipolar children and adolescents.
    Jolin EM; Weller EB; Weller RA
    Curr Psychiatry Rep; 2008 Apr; 10(2):123-9. PubMed ID: 18474202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of children and adolescents with bipolar disorder.
    Kowatch RA; DelBello MP
    Psychiatr Clin North Am; 2005 Jun; 28(2):385-97. PubMed ID: 15826738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenomenology and comorbidity of dysthymic disorder in 100 consecutively referred children and adolescents: beyond DSM-IV.
    Masi G; Millepiedi S; Mucci M; Pascale RR; Perugi G; Akiskal HS
    Can J Psychiatry; 2003 Mar; 48(2):99-105. PubMed ID: 12655907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.